Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Purified Chick Embryo Cell Rabies Vaccine: Economical Multisite Intradermal Regimen for Post-Exposure Prophylaxis

Pravan Suntharasamai, M. J. Warrell, Chaisin Viravan, Pornthep Chanthavanich, Sornchai Looareesuwan, Achara Supapochana, Juntra Karbwang Wichai Supanaranond, Sunee Chittamas, U. Bijok and D. A. Warrell
Epidemiology and Infection
Vol. 99, No. 3 (Dec., 1987), pp. 755-765
Stable URL: http://www.jstor.org/stable/3863325
Page Count: 11
  • Read Online (Free)
  • Download ($49.00)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Purified Chick Embryo Cell Rabies Vaccine: Economical Multisite Intradermal Regimen for Post-Exposure Prophylaxis
Preview not available

Abstract

The standard six-dose intramuscular (i.m.) rabies post-exposure vaccine regimen using a new purified chick embryo cell (PCEC) vaccine was compared with two economical multisite intradermal (i.d.) PCEC regimens, a multisite i.m. PCEC schedule and a subcutaneous regimen using a suckling mouse brain (SMB) rabies vaccine manufactured in Thailand. The neutralizing antibody results for the four-site and eight-site i.d. and the standard i.m. PCEC regimens were similar over 3 months. A three-site i.m. PCEC regimen had no advantage. The SMB vaccine gave the lowest antibody levels. Human rabies immune globulin therapy significantly increased the GMT of all groups on day 7, unlike equine antirabies serum (EARS). Both antisera suppressed antibody responses to PCEC on days 14 and 28. Three generalized reactions probably related to EARS were the only serious side effects. An eight-site i.d. PCEC vaccine regimen proved as immunogenic as the routine i.m. schedule and, if implemented as post-exposure prophylaxis, would be the cheapest widely available tissue culture vaccine regimen. The protective efficiency should now be tested in patients bitten by rabid animals.

Page Thumbnails

  • Thumbnail: Page 
755
    755
  • Thumbnail: Page 
756
    756
  • Thumbnail: Page 
757
    757
  • Thumbnail: Page 
758
    758
  • Thumbnail: Page 
759
    759
  • Thumbnail: Page 
760
    760
  • Thumbnail: Page 
761
    761
  • Thumbnail: Page 
762
    762
  • Thumbnail: Page 
763
    763
  • Thumbnail: Page 
764
    764
  • Thumbnail: Page 
765
    765